Works matching IS 02780232 AND DT 2018 AND VI 36 AND IP 1

Results: 61
    1
    2
    3
    4

    Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

    Published in:
    2018
    By:
    • Klener, Pavel;
    • Fronkova, Eva;
    • Belada, David;
    • Forsterova, Kristina;
    • Pytlik, Robert;
    • Kalinova, Marketa;
    • Simkovic, Martin;
    • Salek, David;
    • Mocikova, Heidi;
    • Prochazka, Vit;
    • Blahovcova, Petra;
    • Janikova, Andrea;
    • Markova, Jana;
    • Obr, Ales;
    • Berkova, Adela;
    • Kubinyi, Jozef;
    • Vaskova, Martina;
    • Mejstrikova, Ester;
    • Campr, Vit;
    • Jaksa, Radek
    Publication type:
    journal article
    5
    6
    7
    8
    9

    Issue Information.

    Published in:
    Hematological Oncology, 2018, v. 36, n. 1, p. 1, doi. 10.1002/hon.2474
    Publication type:
    Article
    10
    11
    12

    FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.

    Published in:
    2018
    By:
    • Fracchiolla, Nicola S.;
    • Artuso, Silvia;
    • Cortelezzi, Agostino;
    • Pelizzari, Anna M.;
    • Tozzi, Paola;
    • Bonfichi, Maurizio;
    • Bocchio, Federica;
    • Gargantini, Livio;
    • De Rosa, Elisa;
    • Vighi, Giuseppe D.;
    • Prestini, Lucia;
    • Sammassimo, Simona;
    • Frungillo, Niccolò;
    • Pasquini, Maria C.;
    • Ragazzi, Alessandra;
    • Boghi, Daniele;
    • Pastore, Alessia;
    • Lanzi, Eraldo;
    • Gritti, Giuseppe;
    • Quaresmini, Giulia
    Publication type:
    journal article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).

    Published in:
    2018
    By:
    • Nakasone, Hideki;
    • Terasako‐Saito, Kiriko;
    • Hirano, Teiichi;
    • Wake, Atsushi;
    • Shimizu, Seiichi;
    • Kurita, Naoki;
    • Yamazaki, Etsuko;
    • Usuki, Kensuke;
    • Akazawa, Kohei;
    • Kanda, Junya;
    • Minauchi, Koichiro;
    • Yamamoto, Go;
    • Tanimoto, Shiori;
    • Kamoshita, Masaharu;
    • Yokoyama, Yasuhisa;
    • Miyaoka, Etsuo;
    • Ota, Shuichi;
    • Kako, Shinichi;
    • Izutsu, Koji;
    • Kanda, Yoshinobu
    Publication type:
    journal article
    31

    Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.

    Published in:
    2018
    By:
    • Biasoli, Irene;
    • Castro, Nelson;
    • Delamain, Marcia;
    • Silveira, Talita;
    • Farley, James;
    • Simões, Belinda Pinto;
    • Solza, Cristiana;
    • Praxedes, Monica;
    • Baiocchi, Otávio;
    • Gaiolla, Rafael;
    • Franceschi, Fernanda;
    • Sola, Caroline Bonamin;
    • Boquimpani, Carla;
    • Clementino, Nelma;
    • Perini, Guilherme;
    • Pagnano, Kátia;
    • Steffenello, Giovanna;
    • Tabacof, Jacques;
    • de Freitas Colli, Gilberto;
    • Soares, Andrea
    Publication type:
    journal article
    32
    33

    Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.

    Published in:
    2018
    By:
    • Gobba, Stefania;
    • Moccia, Alden A.;
    • Gulden‐Sala, Wiebke;
    • Conconi, Annarita;
    • Diem, Stefan;
    • Cascione, Luciano;
    • Iacoboni, Gloria;
    • Margiotta‐Casaluci, Gloria;
    • Aprile von Hohenstaufen, Kathrin;
    • Stathis, Anastasios;
    • Hitz, Felicitas;
    • Pinotti, Graziella;
    • Gaidano, Gianluca;
    • Zucca, Emanuele;
    • Gulden-Sala, Wiebke;
    • Margiotta-Casaluci, Gloria
    Publication type:
    journal article
    34
    35
    36
    37
    38
    39
    40

    Comparison of JAK2<sup>V617F</sup> -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.

    Published in:
    2018
    By:
    • Latagliata, Roberto;
    • Polverelli, Nicola;
    • Tieghi, Alessia;
    • Palumbo, Giuseppe Alberto;
    • Breccia, Massimo;
    • Sabattini, Elena;
    • Villari, Loredana;
    • Riminucci, Mara;
    • Valli, Riccardo;
    • Catani, Lucia;
    • Alimena, Giuliana;
    • Ottaviani, Emanuela;
    • Fama, Angelo;
    • Martinelli, Giovanni;
    • Perricone, Margherita;
    • Spinsanti, Marco;
    • Cavo, Michele;
    • Vianelli, Nicola;
    • Palandri, Francesca
    Publication type:
    journal article
    41

    Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study.

    Published in:
    2018
    By:
    • Palandri, Francesca;
    • Tiribelli, Mario;
    • Benevolo, Giulia;
    • Tieghi, Alessia;
    • Cavazzini, Francesco;
    • Breccia, Massimo;
    • Bergamaschi, Micaela;
    • Sgherza, Nicola;
    • Polverelli, Nicola;
    • Crugnola, Monica;
    • Isidori, Alessandro;
    • Binotto, Gianni;
    • Heidel, Florian H.;
    • Buccisano, Francesco;
    • Martino, Bruno;
    • Latagliata, Roberto;
    • Spinsanti, Marco;
    • Kallenberg, Lydia;
    • Palumbo, Giuseppe Alberto;
    • Abruzzese, Elisabetta
    Publication type:
    journal article
    42
    43
    44

    Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.

    Published in:
    2018
    By:
    • Akahoshi, Yu;
    • Kimura, Shun‐ichi;
    • Gomyo, Ayumi;
    • Hayakawa, Jin;
    • Tamaki, Masaharu;
    • Harada, Naonori;
    • Kusuda, Machiko;
    • Kameda, Kazuaki;
    • Ugai, Tomotaka;
    • Wada, Hidenori;
    • Ishihara, Yuko;
    • Kawamura, Koji;
    • Sakamoto, Kana;
    • Sato, Miki;
    • Terasako‐Saito, Kiriko;
    • Kikuchi, Misato;
    • Nakasone, Hideki;
    • Kako, Shinichi;
    • Kanda, Yoshinobu;
    • Kimura, Shun-Ichi
    Publication type:
    journal article
    45
    46

    Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.

    Published in:
    2018
    By:
    • Luminari, Stefano;
    • Viel, Elda;
    • Ferreri, Andrés José Maria;
    • Zaja, Francesco;
    • Chimienti, Emanuela;
    • Musuraca, Gerardo;
    • Tucci, Alessandra;
    • Balzarotti, Monica;
    • Tani, Monica;
    • Salvi, Francesca;
    • Pesce, Emanuela A.;
    • Ferrari, Angela;
    • Liberati, Anna M.;
    • Spadea, Antonio;
    • Marino, Dario;
    • Bruno‐Ventre, Maria;
    • Volpetti, Stefano;
    • Bottelli, Chiara;
    • Ravaioli, Elena;
    • Merli, Francesco
    Publication type:
    journal article
    47
    48
    49
    50